The size of the defibrillators market in North America was approximately USD 4.73 billion in 2022 and is projected to grow at a CAGR of 7.3% to reach USD 6.73 billion by 2027.
The growing elderly population primarily drives the market for defibrillators in North America, an increase in the prevalence of cardiac disorders, increase in the rapid innovations and technical developments with life-saving devices.
People opting for early defibrillation as the sooner someone is defibrillated after a cardiac arrest, the higher the chances of survival. It is basically due to the flow of oxygenated blood around the body, which decreases and finally ceases if the heart stops pumping efficiently. When vital organs are deprived of oxygen-rich blood, they begin to die.
Increase the survival rates by 50-70 percent if the defibrillator is used within 3-5 minutes of collapsing of the patient. Also, an increase in the awareness of the importance of good cardiac health and market players are estimated to further drive the defibrillators market growth in North America.
Due to an increase in risk factors like skin burns, myocardial necrosis, side effects, fear of implantation, spreading of infection with rising in the cost of the medical devices. Also, a rise in the number of product failures, lack of awareness in some areas is estimated to hamper the market growth of the defibrillators.
Impact of COVID-19 on the North American defibrillators market:
COVID-19 has hit lots of sectors and created a huge impact on supply and demand rates. With increasing in cost and demand rates. Due to the delay of cardiovascular operations classified as elective surgeries, the market for defibrillators suffered a negative growth rate of 7.20 percent from 2019 to 2020. In 2022, the market is anticipated to expand at an annual rate of 8.15 percent. COVID-19 pandemic has changed many elements in the healthcare sector, including the treatment for cardiac arrest; therefore, concentrating on the defibrillation techniques can help reduce delayed treatments of the patients.
This research report on the North American defibrillators market has been segmented and sub-segmented into the following categories.
By Product:
By End User:
By Country:
Regionally, North America was leading the global defibrillator market in 2020. Defibrillators are of different types: manual external defibrillator, manual internal defibrillator, automated external defibrillator (AED), implanted cardioverter-defibrillator (ICD), and wearable cardiac defibrillator are all examples of these devices accounting for 35.0 percent of sales. This is due to the presence of numerous firms in the US. There are presently about 3.2 million AEDs in public locations. Still, more than 30 million AEDs are needed to ensure adequate coverage and increase the national SCA survival rate, which is currently less than 8%.
Each year up to 45,000 Canadians experiences sudden cardiac arrest, according to the Heart and Stroke Foundation of Canada. It's critical to get cardiopulmonary resuscitation (CPR) and defibrillation as soon as possible following a cardiac arrest (1 to 3 minutes;) therefore, automated external defibrillators are used as they are small and portable and have 75 percent of surviving chances.
KEY MARKET PLAYERS:
A few of the prominent companies leading the North America defibrillators market profiled in the report are Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Implantable Cardioverter Defibrillators (ICDS)
5.1.2.1 Transvenous Implantable Cardioverter Defibrillators (T-ICDS)
5.1.2.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
5.1.2.1.2 Dual-Chamber ICDS
5.1.2.1.3 Single-Chamber ICDS
5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
5.1.3 External Defibrillators
5.1.3.1 Automated External Defibrillators (AEDS)
5.1.3.1.1 Semi-Automated External Defibrillators
5.1.3.1.2 Fully Automated External Defibrillators
5.1.3.2 Manual External Defibrillators
5.1.3.3 Wearable Cardioverter Defibrillators (WCDS)
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals, Clinics, & Cardiac Centers
5.2.3 Pre-Hospitals
5.2.4 Public Access Markets
5.2.5 Home Care
5.2.6 Alternate Care Markets
5.2.7 Y-o-Y Growth Analysis, By End User
5.2.8 Market Attractiveness Analysis, By End User
5.2.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic PLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 Philips Healthcare (A Division of Koninklijke Philips N.V.)
8.5 Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
8.6 Biotronik Se & Co.Kg
8.7 Physio-Control International, Inc.
8.8 Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
8.9 Sorin Group (Now Livanova PLC)
8.10 Nihon Kohden Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
